Work

Changes in Oncology Medication Use After Withdrawal of Accelerated Approval

Year: 2025

Type: article

Abstract: This cohort study assesses changes in cancer drug use after negative confirmatory trials and removal of accelerated approval indications from US Food and Drug Administration–approved labeling.

Source: JAMA Oncology

DOI: 10.1001/jamaoncol.2025.0359

Authors: Catherine S. Hwang, Aaron S. Kesselheim, Amar H. Kelkar, Edward R. Scheffer Cliff, Benjamin N. Rome

Institutions: Brigham and Women's Hospital, Oregon Health & Science University, Portland VA Medical Center, VA Portland Health Care System, Harvard University, Dana-Farber Cancer Institute, The Royal Melbourne Hospital, The University of Melbourne, Peter MacCallum Cancer Centre

Language: English

Topic: Pharmaceutical Economics and Policy

Subfield: Economics and Econometrics

Field: Economics, Econometrics and Finance

Domain: Social Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W4409140674

FWCI: 2.918

Cites: 5

Cited by: 3

Related to: 10